Navigation
Company
Our Science
mTOR Pathway
TSC1
&
TSC2
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Clinical Trials
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: November 17, 2023
Home
2023
November
17
17
Nov
2023
Phase 2, Multicenter, Global, Open-Label Basket Trial of
nab
-Sirolimus for Patients With Inactivating Alterations in
TSC1
and
TSC2
(PRECISION 1)
0
1
November 17, 2023
Phase 2, Multicenter, Global, Open-Label Basket Trial of nab-Sirolimus for Patients With Inactivating Alterations in TSC1 and TSC2 (PRECISION 1)
November 17, 2023
17
Nov
2023
Response to Treatment With
nab
-Sirolimus Among Patients With Malignant PEComa of Uterine Origin: A Subanalysis From AMPECTÂ
0
0
November 17, 2023
Response to Treatment With nab-Sirolimus Among Patients With Malignant PEComa of Uterine Origin: A Subanalysis From AMPECTÂ
November 17, 2023
